Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Liminal BioSciences Inc. LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Post by Redj4444on Jun 23, 2020 10:32pm
201 Views
Post# 31184074

Newcamo ou NewCon arrete de repetter tes vieux messages, Si

Newcamo ou NewCon arrete de repetter tes vieux messages, Si Si ce produit etait vraiment bon ca fait  longtemps que la FDA  l'aurait approuv. Mais avec un PDG comme Galbraith a 12.6 millions qui a meme pas le coeur d'habiter au Qubec ca ne bouge pas beaucoup. Bonne chance quand meme
<< Previous
Bullboard Posts
Next >>